Universidad Nacional Autónoma de México-ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Bioinformatics-Based Characterization of Proteins Related to SARS-CoV-2 Using the Polarity Index Method® (PIM®) and Intrinsic Disorder Predisposition

    Current Proteomics, Vol. 19, Núm. 1, pp. 51-64

  2. Characterization of Proteins from Putative Human DNA and RNA Viruses

    Current Proteomics, Vol. 19, Núm. 1, pp. 65-82

2021

  1. Bioinformatics-based identification of proteins expressed by arthro-pod-borne viruses transmitted by aedes aegypti mosquito

    Current Proteomics, Vol. 18, Núm. 1, pp. 81-94

  2. Bioinformatics-based identification of selective cationic amphipatic antibacterial peptides: Aurein 1.2 variants case

    Current Proteomics, Vol. 18, Núm. 4, pp. 505-518

  3. Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas

    European Journal of Endocrinology, Vol. 185, Núm. 4, pp. 485-496

  4. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  5. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4

2019

  1. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 11, pp. 1592-1600

  2. Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout

    Arthritis Care and Research, Vol. 71, Núm. 3, pp. 427-434

2017

  1. Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015

    The Lancet, Vol. 390, Núm. 10091, pp. 231-266

2014

  1. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: A prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)

    Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 275-284

2012

  1. Developing a provisional definition of flare in patients with established gout

    Arthritis and Rheumatism, Vol. 64, Núm. 5, pp. 1508-1517

  2. Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: A randomized controlled trial

    Journal of Rheumatology, Vol. 39, Núm. 9, pp. 1859-1866